SynthesisAdvances in therapy2025

Efanesoctocog Alfa Versus Emicizumab in Adolescent and Adult Patients With Haemophilia A Without Inhibitors.

María Teresa Álvarez Román et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.